HealthEquity (FRA:2HE) Other Financing: €9 Mil (TTM As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
91 GF Score
Price €83.00
GF Value €88.45
! 3 Warning Signs
View Full Analysis

What is HealthEquity Other Financing?

HealthEquity FRA:2HE +0.61% 91 Other Financing is €9 Mil as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 91/100 and a GF Value™ of €88.45. The stock has 3 warning signs investors should review.

HealthEquity's Other Financing for the three months ended in Apr. 2026 was €1 Mil.

HealthEquity's Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 was €9 Mil.

HealthEquity Other Financing Historical Data

* Premium members only.

The historical data trend for HealthEquity's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Other Financing Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.65 5.64 6.73 3.92 10.45

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 7.39 -4.27 5.28 0.97
FRA:2HE
91GF Score
HealthEquity Inc FRA:2HE
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €9 Mil mean?
HealthEquity (FRA:2HE) has a Other Financing of €9 Mil as of Apr. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for HealthEquity and its competitors.
Is HealthEquity's Other Financing too high?
HealthEquity's current Other Financing is €9 Mil. Overall, HealthEquity has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Other Financing compare to HNGE and TEM?
HealthEquity's Other Financing of €9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for HealthEquity and its competitors. HealthEquity's current Other Financing is €9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Other Financing of €9 Mil. The stock's GF Value™ is €88.45, compared to a current price of €83.00 — trading 6.2% below its estimated fair value. The current Other Financing is €9 Mil. HealthEquity's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Other Financing is €9 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €83.00 is trading 6.2% below its estimated GF Value™ of €88.45.

Key valuation signals for FRA:2HE:

  • Other Financing: €9 Mil
  • GF Value™: €88.45 vs. price of €83.00 (6.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
91GF Score

Get the complete analysis for FRA:2HE

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.00
Price
€88.45
GF Value